Sam Waksal, the former chief executive of embattled biotech firm ImClone Systems Inc. (IMCL), was arrested by the FBI on Wedneday and charged with conspiracy to commit securities fraud.

ImClone Systems, a biotechnology company focused on developing cancer medicines, said yesterday it was considering a buyout offer from a "large pharmaceutical company" that easily tops an earlier ...

2002-08-08 04:00:00 PDT New York-- Sam Waksal, the former chief executive of ImClone Systems, was indicted Wednesday on charges of insider trading, bank fraud, forging a signature and destroying ...

ImClone Systems almost died from it four years ago, and it's in for another gloppy ladling of buzz - welcome or not - now that legendary corporate raider Carl Icahn has ...

1984 - ImClone Systems Inc. founded by Sam and Harlan Waksal as a drug discovery company. 1986 - ImClone opens labs in Manhattan. 1991 - ImClone becomes a publicly traded company.

ImClone Officials Ordered Shredders. By Justin Gillis. September 14, 2002. Samuel and Harlan Waksal, the two brothers who ran ImClone Systems Inc., ordered shredders ...

Harlan Waksal, tapped three weeks ago to take the reins from his brother at struggling biotech ImClone Systems Inc., faces a week of grilling from shareholders and lawmakers about whether company ...

ImClone Systems Inc. said it agreed in principle to settle two lawsuits related to the failed regulatory application for its cancer drug Erbitux. The settlements will cause the New York-based ...

BOSTON (CBS.MW) -- ImClone Systems announced Monday that it had filed its delayed annual report with regulators, a significant step toward regaining compliance with Nasdaq listing requirements ...

LONDON (CBS.MW) -- Shares of biotech ImClone Systems traded down 10 percent in speculative pre-open trade to $72.35 on the Archipelago ECN. The stock was one of the top 10 in volume for the ECN in ...